Clinical trial
Cilnidipine Effect on High Blood Pressure and Cerebral Perfusion in Ischemic…
NCT00325637 · Boryung Pharmaceutical Co., Ltd, Industry · Completed
Key facts
| NCT number | NCT00325637 |
|---|---|
| Title | Cilnidipine Effect on High Blood Pressure and Cerebral Perfusion in Ischemic Stroke Patients With Hypertension |
| Official title | A Multi-Center, Double Blind, Randomized and Non-Inferiority Clinical Study of Cilnidipine to Compare the Effects on Cerebral Blood Flow With Losartan in Patients With Ischemic Stroke Hypertension |
| Lead sponsor | Boryung Pharmaceutical Co., Ltd, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension, Stroke |
| Intervention type | Drug |
| Interventions | cilnidipine |
| Enrollment | 250 |
| Start date | Jan 1, 2005 |
| Primary completion | Jul 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | May 15, 2006 |
| Last update posted | Dec 12, 2008 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: